FindTrial
Sign In

Phase 3,randomized,double-blind,clinical trial of IKH-01 for treatment of dysmenorrhea associated with endometriosis.

Phase 3,randomized,double-blind,clinical trial of IKH-01 for treatment of dysmenorrhea associated with endometriosis.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220111
Enrollment
Unknown
Registered
2005-09-13
Start date
2005-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorrhea associated with endometriosis.

Interventions

investigational material(s) Generic name etc : IKH-01 INN of investigational material : Therapeutic category code : 248 Mixed hormone preparations Dosage and Administration for Investigational materi

Sponsors

Nobelpharma Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Age limit:minimum 18years dysmenorrhea associated with endometriosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026